N/A N=27 Randomized Treatment

Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program

Stimulant Use

Bottom Line

View on ClinicalTrials.gov: NCT05787847 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2025

Primary outcome: Primary: Stimulant Free Urine Sample — 6.1; 23.6 % stimulant-negative urine drug test

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Incentives for Abstinence (Behavioral); Health Education (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: University of Vermont
Primary completion: Jul 2024

Outcome Measures

Outcome	Result	p-value
PRIMARY Stimulant Free Urine Sample	6.1; 23.6	—

Summary

The goal of this randomized control pilot study is to learn about a financial incentives intervention among individuals who use stimulants and take part in a community-based syringe exchange program. The main question it aims to answer is how financial incentives for not using stimulants will impact stimulant use. Participants in the experimental group will have the opportunity to earn financial incentives for providing a negative urine sample for stimulants using a point-of-care test, which indicates abstinence from stimulant use, along with health education on the health risks of stimulant use and substance injection. Researchers will compare the experimental group to the control group who will receive health education on the health risks of stimulants use and injection.

Eligibility Criteria

Inclusion Criteria

be 18 years or older
report using stimulants in the past 30 days
meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnosis for stimulant use disorder at a moderate or severe level (i.e., 6 or more of the 11 criteria)
participation in services at syringe exchange program

Exclusion Criteria

failure to meet one or more inclusionary criteria
individuals who are cognitively impaired by their drug use or psychiatric conditions that could preclude informed consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05787847). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.